首页 › 基金 › Redmile Group, LLC › ATRA
Redmile Group, LLC 对 ATRA 的持仓历史
ATARA BIOTHERAPEUTICS INC · 医疗保健
Redmile Group, LLC 在 Q2 2026 的 13F 申报中披露持有 ATRA(ATARA BIOTHERAPEUTICS INC)441,701 股,市值约 US$5.1M,约占其申报组合的 0.34%,在其申报持仓中市值排名第 34 位。 Redmile Group, LLC 最近 12 个申报季度中有 12 个季度披露了 ATRA 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Redmile Group, LLC 对 ATRA 的持仓演变
Redmile Group, LLC 于 Q3 2023 首次披露 ATRA 持仓:6,280,813 股(约 US$9.3M)。 在 12 次申报中,Redmile Group, LLC 2 次增持、2 次减持、7 次保持不变。 最近一期申报(Q2 2026)显示持股 441,701 股、市值约 US$5.1M。 持仓曾出现大幅变动:Q4 2023 增持约 45% (随后一个季度股价上涨 35%)、Q2 2024 减持约 95% (随后一个季度股价下跌 4%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 6.28M | $9.30M | 新进 |
| Q4 2023 | 9.11M | $4.67M | 增持 |
| Q1 2024 | 9.26M | $6.43M | 增持 |
| Q2 2024 | 452.27K | $3.84M | 减持 |
| Q3 2024 | 452.27K | $3.68M | 持有 |
| Q4 2024 | 441.70K | $5.88M | 减持 |
| Q1 2025 | 441.70K | $2.62M | 持有 |
| Q2 2025 | 441.70K | $3.41M | 持有 |
| Q3 2025 | 441.70K | $6.33M | 持有 |
| Q4 2025 | 441.70K | $7.99M | 持有 |
| Q1 2026 | 441.70K | $2.09M | 持有 |
| Q2 2026 | 441.70K | $5.07M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ATRA 与 13F 数据
ATRA(ATARA BIOTHERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 12 只申报持有 ATRA,申报仓位最大的包括:EcoR1 Capital, LLC (US$17.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 Redmile Group, LLC
常见问题
How long has Redmile Group, LLC held ATRA?
Redmile Group, LLC has disclosed ATRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Redmile Group, LLC's current position in ATRA?
As of Q2 2026, Redmile Group, LLC holds 441.70K shares of ATRA (ATARA BIOTHERAPEUTICS INC), valued at $5.07M, representing 0.34% of its reported portfolio and ranking #34.
Has Redmile Group, LLC been buying or selling ATRA?
In the latest 13F filing (Q2 2026), Redmile Group, LLC held unchanged its position in ATRA.
Which other funds hold ATRA?
Other major institutional holders of ATRA include EcoR1 Capital, LLC, among 12 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.